Skip to main content

VR Adviser, LLC

SEC CIK
0001615982
Latest filing
Aug 14, 2026

ALGS holding history

Aligos Therapeutics, Inc. in every 13F filed by VR Adviser, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ALGS overviewAll 13F holders of ALGSFull Q2 2026 holdings

Shares (Q3 2021)
0
Sold out in Q3 2021
Value
$0
% of portfolio
0.0%
Quarters held
2
Since Q1 2021
Holdings of ALGS by VR Adviser, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20210$00.0%−408,377−100.0%Sold outHolders
Q2 2021408,377$8.32M1.0%00.0%UnchangedHolders
Q1 2021408,377$9.29M1.0%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.